These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 34405295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W.
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [Abstract] [Full Text] [Related]

  • 3. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 4. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter arterial chemoembolization alone versus combined with microwave ablation for recurrent small hepatocellular carcinoma after resection: a retrospective comparative study.
    Ji J, Yang W, Shi HB, Liu S, Zhou WZ.
    BMC Gastroenterol; 2022 Jun 29; 22(1):321. PubMed ID: 35768773
    [Abstract] [Full Text] [Related]

  • 6. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q, Zhou X, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Liu L, Yan Z.
    Front Immunol; 2022 Jun 29; 13():1097625. PubMed ID: 36703965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, Sun HL, An C, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Eur Radiol; 2020 Apr 29; 30(4):2377-2390. PubMed ID: 31900694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma.
    Lee S, Jeong YY, Lee BC, Shin SS, Heo SH, Kim HO, Park C, Jeong WG.
    J Korean Med Sci; 2023 Oct 30; 38(42):e362. PubMed ID: 37904659
    [Abstract] [Full Text] [Related]

  • 13. Drug-eluting beads-transarterial chemoembolization plus microwave ablation is an effective and safe treatment strategy in treating hepatocellular carcinoma adjacent to gallbladder.
    Cai L, Li H, Guo J, Zhao W, Li Y, Duan Y, Hou X, Cheng L, Du H, Shao X, Diao Z, Hao Y, Li C.
    Am J Transl Res; 2021 Oct 30; 13(7):7677-7686. PubMed ID: 34377244
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Oct 30; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 15. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study.
    Shi Q, Wang F, Du N, Zhou Y, Zhou X, Ma J, Yang M, Zhang Z, Yu J, Zhang W, Luo J, Liu L, Yan Z.
    Clin Res Hepatol Gastroenterol; 2022 Oct 30; 46(7):101986. PubMed ID: 35772684
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study.
    Cai L, Li H, Guo J, Zhao W, Duan Y, Hou X, Cheng L, Du H, Shao X, Diao Z, Li C.
    Clin Res Hepatol Gastroenterol; 2021 Jul 30; 45(4):101535. PubMed ID: 33121882
    [Abstract] [Full Text] [Related]

  • 19. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y, Yu H, Qi L, Liu C, Feng Y, Qi J, Li J, Zhu Q.
    Int J Hyperthermia; 2022 Jul 30; 39(1):455-465. PubMed ID: 35271786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.